BioNotebook: Three potential IPOs and a venture capital deal; Dermira, Rhythm, Syndax, OncoPep

Dermira revealed plans for a $75m initial public offering on 27 August, just one week after the company closed a $51m Series C venture capital funding round.

Dermira revealed plans for a $75m initial public offering on 27 August, just one week after the company closed a $51m Series C venture capital funding round.

Before the Series C, Redwood City, California-based Dermira had just $9.8m in cash as of 30 June. The company said...

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Alimentary/Metabolic

More from Therapeutic Category